DYNATION, LLC
Dynation, LLC is dedicated to expanding the field of nanometric drug formulation by developing novel nanoparticles and formulations using self-assembly synthetic methods. An important new nanoparticle is the lipoleosome, which has a significantly higher payload for lipophilic compounds. Nanometric drug formulation has the potential to increase bioavailability, enable drug targeting and lower systemic drug concentrations.
UEL Internal Client Highlight: Dynation
Dr. Eric Morrison, founder and CEO of
Dynation, has been growing his start-up dermatological biopharma company in the UEL Garage.
While gaining support such as federal SBIR grant funding, Dynation utilized Minnesota’s science– and technology– focused intern program, SciTechsperience. The two interns at left are Douglas Nelson and Leah Schmidt. Douglas is a math and chemistry major at UMN and Leah is a biomedical major at St. Cloud State University.